Anders Martin-Löf Insider Profile
4 Followers
Anders Martin-Löf, Chief Financial Officer at Oncopeptides AB, holds 12.00K shares in Oncopeptides AB (Ticker: SE:ONCO). Most recently, Anders Martin-Löf Bought 2,000 shares of Oncopeptides AB on Aug 23, 2021 for an estimated value of kr82.35K.
Anders Martin-Löf's Trading History
| ONCOOncopeptides AB | Aug 23, 2021 | Chief Financial Officer | Informative Buy | 82.35K | kr21.25K | ||||||||||||||||||||||||||||||||||||
SE:ONCO Insider Shares: 12.00K (1.59%)
| |||||||||||||||||||||||||||||||||||||||||
You May Also Like
Anders Martin-Löf insider profile FAQ
What is the percentage of profitable transactions made by Anders Martin-Löf?
The percentage of profitable transactions made by Anders Martin-Löf is 25%.
What is the average return per transaction made by Anders Martin-Löf?
The average return per transaction made by Anders Martin-Löf is -48.80%.
What stocks does Anders Martin-Löf hold?
Anders Martin-Löf holds: SE:ONCO stocks.
What was Anders Martin-Löf’s latest transaction?
Anders Martin-Löf’s latest transaction was an Informative Buy of kr82.35K.
What was Anders Martin-Löf's most profitable transaction?
Anders Martin-Löf’s most profitable transaction was an Informative Buy of SE:ONCO stock on September 26, 2019. The return on the trade was 8.50%.
What is Anders Martin-Löf's role in Oncopeptides AB?
Anders Martin-Löf's role in Oncopeptides AB is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
